Compound ID | 1865
Class: Beta-lactam (carbapenem)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets. Ertapenem is mainly active against Enterobacteriaceae and has a longer half life than othe carbapenems |
| Description: | Semisynthetic, derived from thienamycin. Longer half live |
| Institute where first reported: | MSD/Merck |
| Year first mentioned: | 1992 |
| Highest developmental phase: | Approved by FDA in 2001 |
| Development status: | Approved, off-patent |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/150610 |
| Guide to Pharmacology: | ertapenem |
| Citations: |
|